RWA Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.5M Sell
271,979
-23,142
-8% -$4.3M 0.63% 23
2025
Q1
$61.8M Sell
295,121
-15,910
-5% -$3.33M 0.78% 21
2024
Q4
$55.3M Buy
311,031
+4,664
+2% +$829K 0.68% 21
2024
Q3
$60.5M Sell
306,367
-13,165
-4% -$2.6M 0.75% 17
2024
Q2
$54.8M Buy
319,532
+12,521
+4% +$2.15M 0.72% 18
2024
Q1
$55.9M Sell
307,011
-12,903
-4% -$2.35M 0.75% 18
2023
Q4
$49.6M Buy
319,914
+235,137
+277% +$36.4M 0.71% 20
2023
Q3
$12.6M Buy
84,777
+2,730
+3% +$407K 0.28% 36
2023
Q2
$11.1M Buy
82,047
+9,818
+14% +$1.32M 0.24% 39
2023
Q1
$11.5M Buy
72,229
+1,544
+2% +$246K 0.28% 32
2022
Q4
$11.1M Buy
70,685
+2,466
+4% +$388K 0.28% 34
2022
Q3
$9.16M Buy
68,219
+1,792
+3% +$241K 0.64% 31
2022
Q2
$10.2M Buy
66,427
+1,715
+3% +$263K 0.69% 26
2022
Q1
$10.5M Buy
64,712
+2,333
+4% +$378K 0.68% 32
2021
Q4
$8.45M Buy
62,379
+1,286
+2% +$174K 0.57% 49
2021
Q3
$6.59M Buy
61,093
+611
+1% +$65.9K 0.49% 59
2021
Q2
$6.81M Sell
60,482
-19,172
-24% -$2.16M 0.51% 57
2021
Q1
$8.62M Buy
79,654
+10,258
+15% +$1.11M 0.7% 41
2020
Q4
$7.44M Sell
69,396
-3,211
-4% -$344K 0.66% 37
2020
Q3
$6.36M Buy
72,607
+5,143
+8% +$451K 0.67% 38
2020
Q2
$6.62M Buy
67,464
+401
+0.6% +$39.4K 0.81% 30
2020
Q1
$5.11M Buy
67,063
+287
+0.4% +$21.9K 0.72% 37
2019
Q4
$5.91M Sell
66,776
-401
-0.6% -$35.5K 0.59% 46
2019
Q3
$5.09M Buy
67,177
+1,582
+2% +$120K 0.54% 47
2019
Q2
$4.77M Sell
65,595
-2,761
-4% -$201K 0.51% 46
2019
Q1
$5.51M Sell
68,356
-283
-0.4% -$22.8K 0.63% 40
2018
Q4
$6.33M Buy
68,639
+5,211
+8% +$480K 0.83% 29
2018
Q3
$6M Buy
63,428
+1,208
+2% +$114K 0.67% 32
2018
Q2
$5.77M Buy
62,220
+915
+1% +$84.8K 0.64% 36
2018
Q1
$5.8M Sell
61,305
-49,168
-45% -$4.65M 0.75% 28
2017
Q4
$10.7M Sell
110,473
-1,364
-1% -$132K 1.2% 15
2017
Q3
$9.94M Sell
111,837
-15,058
-12% -$1.34M 1.12% 15
2017
Q2
$9.2M Buy
126,895
+1,365
+1% +$99K 1.13% 22
2017
Q1
$8.18M Buy
+125,530
New +$8.18M 1.07% 18